This story originally appeared on Zacks
For investors looking for momentum, United States Natural Gas Fund LP UNG is probably a suitable pick. The fund just hit a 52-week high and is up 112.7% from its 52-week low price of $8.22/share.
Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
UNG in Focus
The fund is an exchange-traded security that is designed to track in percentage terms the movements of natural gas prices. UNG issues shares that may be purchased and sold on the NYSE Arca. It has AUM of $274.4 million and charges 1.35% basis points in annual fees.
Why the Move?
The cold wave from Arctic region accelerates electricity demand across the United States, putting focus on natural gas. Considering the scenario, forecasts of colder-than-expected temperatures in the United States are expected to drive natural gas prices. U.S. natural gas futures have now risen to a seven-year high due to supply crunch heading into the winter-heating season. These factors are making funds like UNG more attractive.
More Gains Ahead?
It seems like the fund will remain strong, with a positive weighted alpha of 71.05, which gives cues of further rally.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
United States Natural Gas ETF (UNG): ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research